Kala Bio Inc Expected To Post A Loss Of $2.89 A Share: Earnings Preview

KALA BIO

03/05/2024 16:07

* KALA BIO Inc  KALA.OQ   KALA.O  is expected to show no
change in
quarterly revenue when it reports  results on May 7 (estimated)
for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for KALA BIO Inc is for a
loss of
$2.89 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for KALA BIO
Inc is
$21.00​, above​ its last closing price of $6.75. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023              -3.62      -3.18     Beat    12.2
 Sep. 30 2023  -2.32       -2.15      -3.41     Missed  -58.3
 Jun. 30 2023  -2.82       -3.19      -4.36     Missed  -36.8​
 Mar. 31 2023  -4.52       -4.43      -6.99     Missed  -57.9
 ​​Jan.        -6.64       -6.92      -7.97     Missed  -15.2
 1 0001                                                 
 Sep. 30 2022  -12.00      16.83      19.25     Beat    14.4​
 Jan. 1 0001   -21.83      -20.50     -19.00    Beat    7.3
 Mar. 31 2022  -17.95      -16.90     -22.50    Missed  -33.1
 This summary was machine generated May 3 at 15:07 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)